Characterizing the phenotype of advanced pelvic organ prolapse

Female Pelvic Medicine and Reconstructive Surgery

Volumn 18, Issue 5, 2012, Pages 299-302

  Levin, Pamela J ^a   Visco, Anthony G ^a   Shah, Svati H ^b   Fulton, Rebekah G ^a   Wu, Jennifer M ^a  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Family history; Genetic epidemiology; Pelvic organ prolapse; Phenotype

Indexed keywords

BODY MASS INDEX; CONFIDENCE INTERVAL; ELECTRONIC MEDICAL RECORD; EPIDEMIOLOGIC-STUDY; GENETIC STUDIES; LOGISTIC REGRESSION MODELS; ODDS RATIOS; PELVIC ORGAN PROLAPSE; PHENOTYPE; PHENOTYPING; RECRUITMENT STRATEGIES; SOCIODEMOGRAPHICS; SURGICAL HISTORY; VAGINAL DELIVERY;

HEALTH; LOGISTICS; MEDICAL COMPUTING; REGRESSION ANALYSIS;

MEDICAL PROBLEMS;

AGED; ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; DISEASE COURSE; FEMALE; GENETICS; HUMAN; MIDDLE AGED; PARITY; PELVIC ORGAN PROLAPSE; PHENOTYPE; RISK FACTOR; STATISTICAL MODEL;

AGED; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; PARITY; PELVIC ORGAN PROLAPSE; PHENOTYPE; RISK FACTORS;

EID: 84868242978     PISSN: 21518378     EISSN: None     Source Type: Journal    
DOI: 10.1097/SPV.0b013e31826a53de     Document Type: Article

References (25)

1. Hendrix SL, Clark A, Nygaard I, et al. Pelvic organ prolapse in the women's health initiative: gravity and gravidity. Am J Obstet Gynecol 2002;186:1160.
2. Jelovsek JE, Barber MD. Women seeking treatment for advanced pelvic organ prolapse have decreased body image and quality of life. Am J Obstet Gynecol 2006;194:1455.
3. Subak LL, Waetjen LE, Van Den Eeden S, et al. Cost of pelvic organ prolapse surgery in the United States. Obstet Gynecol 2001;98:646.
4. Sung VW, Washington B, Raker CA. Costs of ambulatory care related to female pelvic floor disorders in the United States. Am J Obstet Gynecol 2010;202(5):483.31-483.e4.
5. Buchsbaum GM, Duecy EE, Kerr LA, et al. Pelvic organ prolapse in nulliparous women and their parous sisters. Obstet Gynecol 2006;108:1388.
6. Jack GS, Nikolova G, Vilain E, et al. Familial transmission of genitovaginal prolapse. Int Urogynecol J Pelvic Floor Dysfiunct 2006;17:498.
7. Allen-Brady K, Norton PA, Farnham JM, et al. Significant linkage evidence for a predisposition gene for pelvic floor disorders on chromosome 9q21. Am J Hum Genet 2009;84:678.
8. Allen-Brady K, Cannon-Albright L, Farnham JM, et al. Identification of six loci associated with pelvic organ prolapse using genome-wide association analysis. Obstet Gynecol 2011;118:1345.
9. Nikolova, G, Lee H, Berkovitz S, et al. Sequence variant in the laminin gamma1 (LAMC1) gene associated with familial pelvic organ prolapse. Hum Genet 2007;120:847.
10. Chen HY, Lin WY, Chen YH, et al. Matrix metalloproteinase-9 polymorphism and risk of pelvic organ prolapse in Taiwanese women. Eur J Obstet Gynecol Reprod Biol 2010;149:222.
11. Chen HY, Chung YW, Lin WY, et al. Collagen type 3 alpha 1 polymorphism and risk of pelvic organ prolapse. Int J Gynaecol Obstet 2008;103:55.
12. Veeramah KR, Connell BA, Pour NA, et al. Little genetic differentiation as assessed by uniparental markers in the presence of substantial language variation in peoples of the Cross River region of Nigeria. BMC Evol Biol 2010;10:92.
13. Hendershot T, Pan H, Haines J, et al. Using the PhenX toolkit to add standard measures to a study. Current Protocols in Human Genetics 2011;71:1.21.1-1.21.18.
14. Swift SE. The distribution of pelvic organ support in a population of female subjects seen for routine gynecologic health care. Am J Obstet Gynecol 2000;183:277.
15. Swift S, Woodman P, O'Boyle A, et al. Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects. Am J Obstet Gynecol 2005;192:795.
16. Nygaard I, Bradley C, Brandt D. Pelvic organ prolapse in older women: prevalence and risk factors. Obstet Gynecol 2004;104:489.
17. Miedel A, Tegerstedt G, Maehle-Schmidt M, et al. Nonobstetric risk factors for symptomatic pelvic organ prolapse. Obstet Gynecol 2009;113:1089.
18. Hattersley AT, McCarthy MI. What makes a good genetic association study? Lancet 2005;366:1315.
19. Hauser ER, Crossman DC, Granger CB, et al. A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD Study. Am J Hum Genet 2004;75:436.
20. Shah SH, Kraus WE, Crossman DC, et al. Serum lipids in the GENECARD study of coronary artery disease identify quantitative trait loci and phenotypic subsets on chromosomes 3q and 5q. Ann Hum Genet 2006;70:738.
21. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987;40:373.
22. Jelovsek JE, Maher C, Barber MD. Pelvic organ prolapse. Lancet 2007;369:1027.
23. Rortveit G, Brown JS, Thom DH, et al. Symptomatic pelvic organ prolapse: prevalence and risk factors in a population-based, racially diverse cohort. Obstet Gynecol 2007;109:1396.
24. Lammers K, Lince SL, Spath MA, et al. Pelvic organ prolapse and collagen-associated disorders. Int Urogynecol J 2012;23:313.
25. Kudish BI, Iglesia CB, Gutman RE, et al. Risk factors for prolapse development in white, black, and Hispanic women. Female Pelvic Med Reconstr Surg 2011;17:80.